Increasing evidence suggests that culturing cancer cells in three dimensions more accurately recapitulates the complexity of tumor biology. Many of these models utilize reconstituted basement membrane derived from animals which contain a variable amount of growth factors and cytokines that can influence the growth of these cell culture models. Here, we describe in detail the preparation and use of PuraMatrix, a commercially available self assembling peptide gel that is devoid of animal-derived material and pathogens to encapsulate and propagate the ovarian cancer cell line, OVCAR-5. We begin by describing how to prepare the PuraMatrix prior to use. Next, we demonstrate how to properly mix the PuraMatrix and cell suspension to encapsulate the cells in the hydrogel. Upon the addition of cell culture media or injection into a physiological environment, the peptide component of PuraMatrix rapidly self assembles into a 3D hydrogel that exhibits a nanometer scale fibrous structure with an average pore size of 5-200 nm 1 . In addition, we demonstrate how to propagate cultures grown in encapsulated PuraMatrix. When encapsulated in PuraMatrix, OVCAR-5 cells assemble into three dimensional acinar structures that more closely resemble the morphology of micrometastatic nodules observed in the clinic than monolayer in vitro models. Using confocal microscopy we illustrate the appearance of representative OVCAR-5 cells encapsulated in PuraMatrix on day 1, 3, 5, and 7 post plating. The use of PuraMatrix to culture cancer cells should improve our understanding of the disease and allow us to assess treatment response in more clinically predictive model systems.
• Gelation is initiated by the addition of salts. Therefore, it is CRITICAL that no salts come in contact with PuraMatrix until gelation is desired; exposure to salts of very low ionic strength (e.g., < 0.05 M) will cause irreversible gelation.
• Leftover stock solutions that are prepared can be used at a later date provided they have not come in contact with salts. You do not need to worry about repeat sonication.
• Air bubbles can be removed aliquoting PuraMatrix into sterile tubes followed by centrifugation.
• Be very careful during media changes as aspiration can easily disrupt the PuraMatrix bed.
• Water Bath Sonicator or Vortex a. Avoid the formation of air bubbles; if they form simply spin down the sterile tubes containing PuraMatrix at 1000 rpm (300 x g) for 5 minutes. b. The total peptide concentration of the undiluted mixture is 10 mg/ml.
3. Two sets of 4 wells will be plated at 2.5 mg/ml and 1.25 mg/ml total peptide concentration, respectively. 4. Dilute the PuraMatrix in each well set with 0.2 μm sterile filtered 20% sucrose and 13.3% sucrose to total peptide concentrations of 5 mg/ml and 2.5 mg/ml, respectively to achieve a 2x concentration of BD PuraMatrix in 10% sucrose. a. To Make 20% sucrose, dilute 10 g of sucrose, then volume to 50 ml water. b. 13% and 10% sucrose can be prepared by diluting the 20% stock solution. i. 13% Sucrose (for every 10 ml): 6.5 ml 20% sucrose + 3.5 ml sterile H2O.
ii. 10% Sucrose (for every 10 ml): 5.0 ml 20% sucrose + 5.0 ml sterile H2O.
Representative Results: a. The master mix should be prepared at twice the desired final concentration of total peptide as it will be diluted with an equal volume of cells during plating.
6. Prepare cell suspensions by trypsinizing cell monolayer cell cultures. a. 2 ml of 0.05% Trypsin EDTA can be used for each T-75 Flask.
7. Neutralize the trypsin by addition of cell culture media containing 10% heat inactivated fetal bovine serum (use at least 2 ml of media per ml of trypsin used in the previous step.) 8. Centrifuge the cells at 1000 rpm (~300 x g) for 5 minutes to create a cell pellet.
1. Resuspend the cells in 10% sterile filtered sucrose. 2. Count the cells and spin down again at 1000 rpm (~300 x g) for 5 minutes to remove trace amounts of salt found in the media. 
